Guest
Editorial
Peter Hajek
Professor of Clinical
Psychology and Director of the Health and Lifestyle Research Unit at the
Wolfson Institute of Preventive Medicine
In my presentation on “Using
nicotine to help smokers quit” at the 6th Global Forum on Nicotine in Warsaw,
Poland, I was comparing the reactions to the launch of nicotine replacement
treatments (NRT) in 1980s with the reactions that have been meeting the recent
advance of alternative nicotine products.
When nicotine chewing gum
first appeared, there were concerns about its safety, its potential to entice
children to nicotine use, and doubts about giving smokers the drug they are
trying to quit.
Evidence and common sense
however prevailed fairly rapidly and NRT was accepted practically universally
as a safe and effective treatment.
The same objections have been
revived by opponents of e-cigarettes, with some new ones added, especially the
claim based on animal studies that nicotine damages adolescent brains (support
of the hypothesis by human data is lacking, e.g. dramatic reductions in
adolescent smoking that took place in a number of countries were not
accompanied by improvements in mental health).
There are also claims that
smokers who switched to vaping did not really quit smoking (they did), that
vaping prevents rather than facilitates quitting (it helps smokers quit), and
that dual use, i.e. combining vaping and smoking, is more risky than smoking
(it reduces toxin intake from smoking).
Evidence and common sense are
facing a much harder battle the second time round.
Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of
Medical Associations in Asia and Oceania
(CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of
India
Past National President
IMA
No comments:
Post a Comment